SCOPE7 LARYNGOSCOPE

MAUDE Adverse Event Report

MAUDE data represents reports of adverse events involving medical devices. This maude entry was filed with the FDA on 2016-07-09 for SCOPE7 LARYNGOSCOPE manufactured by Unk.

Event Text Entries

[49565709] At that doctor's visit, the scope was used. Since then, a very painful sore throat developed slowly and worked further down the throat and "infection" (right side predominantly) - difficulty swallowing, etc. No symptoms were present before the scope was used. Either or both, the scope was jammed down improperly and/or there was an infection on it that was not cleaned off. They put me on a ten-day antibiotic (levofloxacin) which did nothing to help at all. Then, a ten-day (stronger) antibiotic (amox and clavulanate potassium) (875 mg 2/day) plus prednisone. Throat has gotten only slightly better, while other symptoms are worse. Symptoms are now: sore throat; difficulty swallowing; difficulty getting up congestion / hard to clear throat (cilia damage? ); sleeplessness; other cold-like symptoms (weak, aches, sneezing, cough, inflammation of mucosa, etc. ).
Patient Sequence No: 1, Text Type: D, B5


MAUDE Entry Details

Report NumberMW5063361
MDR Report Key5790450
Date Received2016-07-09
Date of Report2016-07-09
Date of Event2016-05-09
Date Added to Maude2016-07-13
Event Key0
Report Source CodeVoluntary report
Manufacturer LinkN
Number of Patients in Event0
Adverse Event Flag3
Product Problem Flag3
Reprocessed and Reused Flag3
Reporter OccupationPATIENT
Health Professional3
Initial Report to FDA3
Report to FDA3
Event Location3
Single Use3
Previous Use Code3
Event Type3
Type of Report0

Device Details

Brand NameSCOPE7 LARYNGOSCOPE
Generic NameLARYNGOSCOPE
Product CodeCAL
Date Received2016-07-09
OperatorHEALTH PROFESSIONAL
Device Availability*
Device Eval'ed by Mfgr*
Device Sequence No1
Device Event Key0
ManufacturerUNK


Patients

Patient NumberTreatmentOutcomeDate
101. Deathisabilit 2016-07-09

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.